Public Health Archives - Page 4 of 33

Cellino CEO Nabiha Saklayen Named EY’s Entrepreneur Of The Year 2025 for New England

June 13, 2025

Parallel Bio Raises $21 Million to Advance Human-Based Drug Discovery, Partners with Centivax on Universal Flu Vaccine

June 13, 2025

athenahealth, Humana, and Your Health Recognized for Reducing Care Gaps and Streamlining Clinician Workflows

June 12, 2025

THIS WEEK'S STORIES

New GI Alliance Surgery Center and Clinic Opens in Bentonville

June 7, 2025

Innospera Pharma Appoints Dr. Glenn Crater as Chief Medical Officer to Guide Lead Drug Candidate Into Clinical Trials

June 9, 2025

SoundHealth’s SONU Band Receives FDA Approval for Pediatric Use in Treating Nasal Congestion and Allergies

June 11, 2025

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Public Health

Genetic Marker Linked to Immunotherapy Resistance in Deadly Skin Cancer, NYU Study Finds

Ontario Brain Injury Association Warns of Hidden Dangers in Surviving Opioid Overdoses

ZOLL and Simon’s Heart Donate AEDs to 32 Youth Organizations Nationwide in Honor of CPR and AED Awareness Week

Affinia Therapeutics and DCM Foundation Launch Awareness Campaign for Genetic Heart Disease BAG3 DCM

Animal Diseases Spreading to New Species, Nearly Half Pose Human Health Risk: Global Report

Most Read

Robotic Pet Startup Tombot Raises $6.1 Million to Launch Therapeutic Companion for Seniors

FDA Approves Merck’s Keytruda for Perioperative Use in Certain Head and Neck Cancer Patients

Cellino CEO Nabiha Saklayen Named EY’s Entrepreneur Of The Year 2025 for New England

Astria Therapeutics Reports Strong Long-Term Results for Navenibart in Hereditary Angioedema Patients

EDITOR PICKS

Cellino CEO Nabiha Saklayen Named EY’s Entrepreneur Of The Year 2025 for New England

Parallel Bio Raises $21 Million to Advance Human-Based Drug Discovery, Partners with Centivax on Universal Flu Vaccine

athenahealth, Humana, and Your Health Recognized for Reducing Care Gaps and Streamlining Clinician Workflows

THIS WEEK'S STORIES

New GI Alliance Surgery Center and Clinic Opens in Bentonville

Innospera Pharma Appoints Dr. Glenn Crater as Chief Medical Officer to Guide Lead Drug Candidate Into Clinical Trials

SoundHealth’s SONU Band Receives FDA Approval for Pediatric Use in Treating Nasal Congestion and Allergies

POPULAR CATEGORY

ABOUT US

FOLLOW US